Skip to main content
SpringerLink
Log in

Hypopituitarism in the elderly: two case-reports with heterogeneous presentation

  • Case Report
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

Hypopituitarism (HYPO) is an under-investigated disease in older patients. Symptoms, which may be life-threatening, are aspecific and often attributed to aging and/or related morbidities. We describe here the cases of two elderly patients who were ultimately diagnosed as having HYPO, the clinical presentations and etiologies of which were different. In the first patient, an invasive non-secreting pituitary macroadenoma causing HYPO was detected on brain morphological evaluation for head trauma secondary to falling. Glucocorticoid replacement therapy was started. Thyroid function evaluation showed hyperthyroidism (due to a known toxic multinodular goiter), which was already on treatment with methimazole; ultimately, after withdrawal of the antithyroid drug, secondary hypothyroidism occurred. The patient underwent non-radical pituitary surgery. Cognitive function, gait impairment and falling, which had previously been attributed only to aging, improved markedly after cortisone acetate and L-thyroxine replacement therapy. The second patient was hospitalized one month after the onset of hypotension, edema and pain in the legs, and progressive psychomotor impairment, which ultimately resulted in an intermittent soporous state. She was diagnosed as having global anterior HYPO secondary to empty sella, which caused severe multifaceted clinical and biochemical abnormalities (hyponatremia, pancytopenia, rhabdomyolysis). After treatment with i.v. fluids and hydrocortisone, the patient’s clinical condition and biochemical alterations improved, and normalized over time with oral cortisone acetate and L-thyroxine combination therapy. Several protean symptoms that impair the quality of life of elderly patients are usually ascribed to aging. Such symptoms should be investigated with regard to possible HYPO, treatment of which can result in significant clinical benefit.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Toogood AA, Stewart PM. Hypopituitarism: clinical features, diagnosis and management. Endocrinol Metab Clin North Am 2008; 37: 235–61.

    Article  PubMed  CAS  Google Scholar 

  2. Schneider HJ, Aimaretti G, Kreitschmann-Andermahr I, Stalla GK, Ghigo E. Hypopituitarism. Lancet 2007; 369: 1461–70.

    Article  PubMed  CAS  Google Scholar 

  3. Vance ML. Hypopituitarism. N Engl J Med 1994; 330: 1651–62.

    Article  PubMed  CAS  Google Scholar 

  4. Prabhakar VKB, Shalet SM. Aetiology, diagnosis, and management of hypopituitarism in adult life. Postgrad Med J 2006; 82: 259–66.

    Article  PubMed  CAS  Google Scholar 

  5. Minniti G, Esposito V, Piccirilli M, Fratticci A, Santoro A, Jaffrain-Rea ML. Diagnosis and management of pituitary tumours in the elderly: a review based on personal experience and evidence of literature. Eur J Endocrinol 2005; 153: 723–35.

    Article  PubMed  CAS  Google Scholar 

  6. Diderich S, Franzen NF, Bähr V, Oelkers W. Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases. Eur J Endocrinol 2003; 148: 609–17.

    Article  Google Scholar 

  7. Chanson P. Severe hyponatremia as a frequent revealing sign of hypopituitarism after 60 years of age. Eur J Endocrinol 2003; 149: 177–8.

    Article  PubMed  CAS  Google Scholar 

  8. Beshyah SA, Johnston DG. Cardiovascular disease and risk factors in adults with hypopituitarism. Clin Endocrinol 1999; 50: 1–15.

    Article  CAS  Google Scholar 

  9. Nilsson B, Gustavasson-Kadaka E, Bengtsson BA et al. Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality. J Clin Endocrinol Metab 2000; 85: 1420–5.

    Article  PubMed  CAS  Google Scholar 

  10. Tomlinson JW, Holden N, Hills RK et al. Association between premature mortality and hypopituitarism. Lancet 2001; 357: 425–31.

    Article  PubMed  CAS  Google Scholar 

  11. Benvenga S, Campenni A, Ruggeri RM, Trimarchi F. Hypopituitarism secondary to head trauma. J Clin Endocrinol Metab 2000; 85: 1353–61.

    Article  PubMed  CAS  Google Scholar 

  12. Bondanelli M, Ambrosio MR, Zatelli MC, De Marinis L, degli Uberti EC. Hypopituitarism after traumatic brain injury. Eur J Endocrinol 2005; 152: 679–91.

    Article  PubMed  CAS  Google Scholar 

  13. Schneider HJ, Kreitschmann-Andermahr I, Ghigo E, Stalla GK, Agha A. Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage. JAMA 2007; 298: 1429–38.

    Article  PubMed  CAS  Google Scholar 

  14. Regal M, Páramo C, Sierra JM, García-Mayor RV. Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain. Clin Endocrinol 2001; 55: 735–40.

    Article  CAS  Google Scholar 

  15. Turner HE, Wass JA. Pituitary tumours in the elderly. Bailliere’s Clin Endocrinol Metab 1999; 11: 407–422.

    Article  Google Scholar 

  16. Johnston S, Hoult S, Chan CA. Falling again. The Lancet 1996; 348: 26.

    Google Scholar 

  17. Cikim A, Dikilitas M, Cikim K. Hypopituitarism in older adults. The report of five cases with different presentations. Geriatrics 2006; 61: 32–5.

    Google Scholar 

  18. Chandler WF, Barkan AL. Treatment of pituitary tumors: a surgical perspective. Endocrinol Metab Clin North Am 2008; 37: 51–66.

    Article  PubMed  Google Scholar 

  19. Faustini-Fustini M, Anagni M. Beyond semantics: defining hyponatremia in secondary adrenal insufficiency. J Endocrinol Invest 2006; 29: 267–9.

    PubMed  CAS  Google Scholar 

  20. Sasaki M, Yuzawa M, Saito T et al. Clinical and laboratory features of hyponatremia-induced myopathy. Clin Exp Nephrol 2007; 11: 283–6.

    Article  PubMed  CAS  Google Scholar 

  21. Nguyen-Michel VH, Schwald N, Hunert S, Chahwakilian A, Debray-Meignan S. Central hypothyroidism allows discovery of a pituitary disease in older people. J Am Geriatr Soc 2007; 55: 630–1.

    Article  PubMed  Google Scholar 

  22. Waise A, Belchetz PE. Unsuspected central hypothyroidism. BMJ 2000; 321: 1275–7.

    Article  PubMed  CAS  Google Scholar 

  23. Nishioka H, Haraoka J. Hypopituitarism and anemia: effect of replacement therapy with hydrocortisone and/or levothyroxine. J Endocrinol Invest 2005; 28: 528–33.

    PubMed  CAS  Google Scholar 

  24. Rudzki Z, Matynia A, Przybylik-Mazurek E et al. Hypopituitarism and hematological abnormalities mimicking myelodysplastic syndrome. Report of four cases. Pol Arch Med Wewn 2003; 110: 1003–11.

    Google Scholar 

  25. Nomiyama J, Shinohara K, Inoue H. Improvement of anemia by recombinant erythropoietin in a patient with postoperative hypopituitarism. Am J Hematol 1994; 47: 249–50.

    Article  PubMed  CAS  Google Scholar 

  26. De Marinis L, Bonadonna S, Bianchi A, Maira G, Giustina A. Extensive clinical experience: primary empty sella. J Clin Endocrinol Metab 2005; 90: 5471–7.

    Article  PubMed  Google Scholar 

  27. Del Monte P, Foppiani L, Cafferata C, Marugo A, Bernasconi D. Primary empty sella: endocrine findings. Endocr J 2006; 53: 803–9.

    Article  PubMed  Google Scholar 

  28. Jeffcoate W. Assessment of corticosteroid replacement therapy in adults with adrenal insufficiency. Ann Clin Biochem 1999; 36: 151–7.

    PubMed  CAS  Google Scholar 

  29. Ten S, New M, MacLaren N. Addison’s disease 2001. J Clin Endocrinol Metab 2001; 86: 2909–22.

    Article  PubMed  CAS  Google Scholar 

  30. Peacey S, Guo C-Y, Robinson SM et al. Glucocorticoid replacement therapy: are patients over treated and does it matter? Clin Endocrinol 1997; 46: 255–61.

    Article  CAS  Google Scholar 

  31. Molitch ME, Clemmons DR, Malozowski S et al. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2006; 91: 1621–34.

    Article  PubMed  CAS  Google Scholar 

  32. Franco C, Johannsson G, Bengtsson BA, Svensson J. Baseline characteristics and effects of growth hormone therapy over two years in younger and elderly adults with adult onset GH deficiency. J Clin Endocrinol Metab 2006; 91: 4408–14.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Endocrinology, Galliera Hospital, Genova, Italy

    Luca Foppiani MD, PhD & Patrizia Del Monte

  2. Division of Neurosurgery, Galliera Hospital, Genova, Italy

    Antonio Ruelle

  3. Unit of Pathology, Galliera Hospital, Genova, Italy

    Paolo Quilici

Authors
  1. Luca Foppiani MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antonio Ruelle
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paolo Quilici
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Patrizia Del Monte
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Luca Foppiani MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Foppiani, L., Ruelle, A., Quilici, P. et al. Hypopituitarism in the elderly: two case-reports with heterogeneous presentation. Aging Clin Exp Res 21, 76–81 (2009). https://doi.org/10.1007/BF03324902

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03324902

Keywords

Search

Navigation